Demirtas Huseyin, Ozer Abdullah, Burak Gulcan Mehmet, Shide Issa, Delibas Hacı, Oktar Gürsel Levent
Department of Cardiovascular Surgery, Gazi University Hospital, Ankara, Türkiye.
Turk Gogus Kalp Damar Cerrahisi Derg. 2024 Jan 29;32(1):97-100. doi: 10.5606/tgkdc.dergisi.2024.25357. eCollection 2024 Jan.
Constrictive pericarditis is quite rare complication of messenger ribonucleic acid-based severe acute respiratory syndrome-Coronavirus 2 (SARS-CoV-2) vaccine. It is a severe clinical picture with clinical symptoms of right ventricular failure. Initial physical examination, laboratory work-up, and chest X-ray may yield non-specific findings. Echocardiography, computed tomography, and cardiac catheterization are other diagnostic tools. Surgery with pericardiectomy is the definitive treatment option. Herein, we report a case of pericardiectomy after constrictive pericarditis associated with the second dose of BNT162b2 vaccine.
缩窄性心包炎是基于信使核糖核酸的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)疫苗相当罕见的并发症。它是一种具有右心室衰竭临床症状的严重临床表现。初始体格检查、实验室检查和胸部X线检查可能会得出非特异性结果。超声心动图、计算机断层扫描和心导管检查是其他诊断工具。心包切除术是最终的治疗选择。在此,我们报告一例与第二剂BNT162b2疫苗相关的缩窄性心包炎后心包切除术的病例。